Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
172 | NTP Immunotoxicity Technical Report Series | book series | 0.133 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | |
171 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 0.111 Q4 | 9 | 2 | 3 | 348 | 0 | 3 | 0.00 | 174.00 | |
170 | NTP Research Report Series | book series | 0.117 Q4 | 3 | 1 | 4 | 21 | 1 | 4 | 0.00 | 21.00 | |
169 | Journal of Experimental Therapeutics and Oncology | journal | 0.108 Q4 | 40 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | |
168 | Molecular and Cellular Pharmacology | journal | 0.133 Q4 | 28 | 3 | 5 | 15 | 0 | 1 | 0.00 | 5.00 | |
167 | National Toxicology Program technical report series | journal | 0.111 Q4 | 22 | 2 | 5 | 185 | 1 | 5 | 0.00 | 92.50 | |
166 | Journal of Caffeine and Adenosine Research | journal | 0.112 Q4 | 1 | 0 | 8 | 0 | 1 | 5 | 0.13 | 0.00 | |
165 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.115 Q4 | 31 | 0 | 10 | 0 | 4 | 10 | 0.00 | 0.00 | |
164 | NTP Technical Report on the Toxicity Studies Series | book series | 0.110 Q4 | 6 | 2 | 10 | 191 | 2 | 9 | 0.14 | 95.50 | |
163 | Current Protocols in Pharmacology | journal | 0.670 Q2 | 39 | 0 | 11 | 0 | 30 | 11 | 0.00 | 0.00 | |
162 | NTP Developmental and Reproductive Toxicity Technical Report Series | book series | 0.111 Q4 | 1 | 0 | 11 | 0 | 0 | 3 | 0.00 | 0.00 | |
161 | Food and Drug Law Journal | journal | 0.145 Q4 | 23 | 12 | 14 | 1814 | 4 | 14 | 0.29 | 151.17 | |
160 | WikiJournal of Medicine | journal | 0.134 Q4 | 4 | 5 | 14 | 385 | 9 | 14 | 0.50 | 77.00 | |
159 | Pharmaceutical Outsourcing | journal | 0.103 Q4 | 7 | 0 | 15 | 0 | 0 | 12 | 0.00 | 0.00 | |
158 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 196 | 5 | 18 | 0.17 | 32.67 | |
157 | Cancer Innovation | journal | 0.389 Q2 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | |
156 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q2 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | |
155 | American Pharmaceutical Review | journal | 0.103 Q4 | 26 | 0 | 29 | 0 | 4 | 27 | 0.00 | 0.00 | |
154 | Journal of Excipients and Food Chemicals | journal | 0.128 Q4 | 17 | 10 | 30 | 330 | 10 | 19 | 0.41 | 33.00 | |
153 | Topics in antiviral medicine | journal | 0.614 Q2 | 46 | 18 | 36 | 403 | 63 | 36 | 1.89 | 22.39 | |
152 | Precision Nanomedicine | journal | 0.219 Q3 | 6 | 14 | 43 | 1070 | 42 | 41 | 1.13 | 76.43 | |
151 | Applied In Vitro Toxicology | journal | 0.321 Q3 | 15 | 16 | 48 | 582 | 67 | 39 | 1.53 | 36.38 | |
150 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.536 Q2 | 82 | 17 | 53 | 3290 | 172 | 53 | 2.83 | 193.53 | |
149 | Journal of Immunotoxicology | journal | 0.711 Q2 | 48 | 9 | 54 | 432 | 176 | 54 | 2.21 | 48.00 | |
148 | ACS Bio and Med Chem Au | journal | 1.036 Q1 | 11 | 48 | 62 | 3007 | 245 | 58 | 3.95 | 62.65 | |
147 | Dissolution Technologies | journal | 0.218 Q3 | 36 | 27 | 69 | 806 | 61 | 65 | 0.90 | 29.85 | |
146 | PPAR Research | journal | 0.698 Q2 | 59 | 15 | 69 | 877 | 199 | 69 | 3.25 | 58.47 | |
145 | Current Cardiovascular Risk Reports | journal | 0.491 Q3 | 34 | 21 | 72 | 1537 | 119 | 72 | 1.94 | 73.19 | |
144 | OpenNano | journal | 0.824 Q1 | 21 | 80 | 73 | 7983 | 473 | 73 | 6.48 | 99.79 | |
143 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | |
142 | Drug Metabolism Reviews | journal | 0.870 Q1 | 108 | 20 | 78 | 2451 | 403 | 78 | 3.73 | 122.55 | |
141 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.415 Q3 | 50 | 25 | 87 | 1741 | 172 | 87 | 1.75 | 69.64 | |
140 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.255 Q3 | 34 | 32 | 88 | 1098 | 151 | 88 | 1.45 | 34.31 | |
139 | Mental Health Clinician | journal | 0.356 Q2 | 23 | 8 | 89 | 238 | 105 | 89 | 1.24 | 29.75 | |
138 | Cancer Nanotechnology | journal | 0.671 Q2 | 36 | 83 | 90 | 4754 | 399 | 89 | 4.21 | 57.28 | |
137 | International Nano Letters | journal | 0.586 Q2 | 26 | 20 | 90 | 1419 | 441 | 90 | 5.05 | 70.95 | |
136 | Pharmacogenetics and Genomics | journal | 0.563 Q1 | 152 | 25 | 97 | 907 | 208 | 95 | 1.94 | 36.28 | |
135 | Pharmacological Reviews | journal | 6.050 Q1 | 254 | 35 | 102 | 13259 | 2111 | 100 | 19.42 | 378.83 | |
134 | Annual Review of Pharmacology and Toxicology | journal | 3.957 Q1 | 224 | 32 | 103 | 4593 | 1346 | 103 | 11.26 | 143.53 | |
133 | Current Therapeutic Research | journal | 0.495 Q3 | 46 | 37 | 110 | 1384 | 214 | 108 | 1.60 | 37.41 | |
132 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.152 Q3 | 43 | 0 | 113 | 0 | 73 | 104 | 0.55 | 0.00 | |
131 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 0.571 Q2 | 81 | 36 | 120 | 1613 | 374 | 110 | 1.73 | 44.81 | |
130 | Nucleic Acid Therapeutics | journal | 1.252 Q1 | 77 | 33 | 125 | 1583 | 502 | 122 | 3.95 | 47.97 | |
129 | Assay and Drug Development Technologies | journal | 0.317 Q3 | 65 | 32 | 126 | 1530 | 234 | 118 | 1.61 | 47.81 | |
128 | Journal of Pharmacy Technology | journal | 0.330 Q3 | 16 | 52 | 133 | 1092 | 149 | 118 | 1.07 | 21.00 | |
127 | Journal of Immunotherapy | journal | 1.263 Q1 | 106 | 44 | 150 | 1376 | 521 | 149 | 3.12 | 31.27 | |
126 | Biologicals | journal | 0.452 Q3 | 66 | 42 | 154 | 1276 | 287 | 152 | 1.49 | 30.38 | |
125 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.694 Q2 | 70 | 55 | 154 | 2186 | 403 | 144 | 2.25 | 39.75 | |
124 | Clinical Neuropharmacology | journal | 0.287 Q3 | 85 | 44 | 156 | 1416 | 149 | 146 | 0.81 | 32.18 | |
123 | Prostaglandins and Other Lipid Mediators | journal | 0.671 Q2 | 86 | 56 | 156 | 3893 | 431 | 151 | 2.43 | 69.52 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®